NASDAQ:WINT

Windtree Therapeutics News Headlines

$2.39
-0.07 (-2.85 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.32
Now: $2.39
$2.49
50-Day Range
$2.14
MA: $3.81
$5.59
52-Week Range
$2.06
Now: $2.39
$10.06
Volume362,246 shs
Average Volume312,882 shs
Market Capitalization$62.75 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25

Headlines

Windtree Therapeutics (NASDAQ WINT) News Headlines Today

SourceHeadline
Windtree Therapeutics, Inc. (NASDAQ:WINT) Director James Huang Buys 150,000 SharesWindtree Therapeutics, Inc. (NASDAQ:WINT) Director James Huang Buys 150,000 Shares
americanbankingnews.com - April 2 at 7:36 PM
Have Insiders Been Buying Windtree Therapeutics, Inc. (NASDAQ:WINT) Shares This Year?Have Insiders Been Buying Windtree Therapeutics, Inc. (NASDAQ:WINT) Shares This Year?
finance.yahoo.com - March 30 at 4:14 PM
Windtree Therapeutics (NASDAQ:WINT) Releases  Earnings Results, Beats Expectations By $0.02 EPSWindtree Therapeutics (NASDAQ:WINT) Releases Earnings Results, Beats Expectations By $0.02 EPS
americanbankingnews.com - March 30 at 7:46 AM
Windtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Up 81.4% in MarchWindtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Up 81.4% in March
americanbankingnews.com - March 30 at 3:52 AM
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business UpdatesWindtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
finance.yahoo.com - March 29 at 7:20 PM
Windtree Therapeutics Announces Closing of $30.0 Million Public OfferingWindtree Therapeutics Announces Closing of $30.0 Million Public Offering
finance.yahoo.com - March 25 at 7:45 PM
Whats Happening With SPWR Stock And WINT Stock Tuesday?What's Happening With SPWR Stock And WINT Stock Tuesday?
msn.com - March 23 at 5:38 PM
Mid-Day Market Update: Crude Oil Down 4.5%; Hoth Therapeutics Shares Spike HigherMid-Day Market Update: Crude Oil Down 4.5%; Hoth Therapeutics Shares Spike Higher
benzinga.com - March 23 at 12:38 PM
Windtree Therapeutics Announces Pricing of $30.0 Million Public OfferingWindtree Therapeutics Announces Pricing of $30.0 Million Public Offering
finance.yahoo.com - March 23 at 12:38 PM
Windtree Therapeutics Announces Proposed Public Offering of Common Stock and WarrantsWindtree Therapeutics Announces Proposed Public Offering of Common Stock and Warrants
finance.yahoo.com - March 22 at 7:36 PM
Windtree Extends Scientific Collaboration in Heart Failure Studying Its SERCA2a Activators with the University of Milan-BicoccaWindtree Extends Scientific Collaboration in Heart Failure Studying Its SERCA2a Activators with the University of Milan-Bicocca
finance.yahoo.com - March 22 at 7:55 AM
Windtree to Present at the Oppenheimer 31st Annual Healthcare ConferenceWindtree to Present at the Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 15 at 9:10 AM
Windtree to Present at the H.C. Wainwright Global Life Sciences ConferenceWindtree to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 8 at 9:03 AM
WINT: Recent News Updates Positive For Lead Assets and ProgramsWINT: Recent News Updates Positive For Lead Assets and Programs
finance.yahoo.com - February 22 at 3:52 PM
Windtree Announces Issuance of New U.S. Patent Covering Technology on Its Redesigned AEROSURF® DeviceWindtree Announces Issuance of New U.S. Patent Covering Technology on Its Redesigned AEROSURF® Device
finance.yahoo.com - February 16 at 7:34 AM
Windtree Strengthens Its Board by Appointing Three New DirectorsWindtree Strengthens Its Board by Appointing Three New Directors
finance.yahoo.com - February 4 at 9:17 AM
Windtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical DevelopmentWindtree Appoints Dr. Joseph Soffer to Lead Cardiovascular Clinical Development
finance.yahoo.com - February 1 at 8:39 PM
Windtree Announces First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19Windtree Announces First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19
finance.yahoo.com - January 6 at 10:32 AM
WINT: Clinical Studies Moving Forward For Both Lead Treatment ProgramsWINT: Clinical Studies Moving Forward For Both Lead Treatment Programs
finance.yahoo.com - November 24 at 1:03 PM
Windtree Therapeutics Reports Third Quarter 2020 Financial Results and Provides Key Business UpdatesWindtree Therapeutics Reports Third Quarter 2020 Financial Results and Provides Key Business Updates
finance.yahoo.com - November 16 at 8:08 AM
Windtree Therapeutics, Inc. Common Stock (WINT)Windtree Therapeutics, Inc. Common Stock (WINT)
nasdaq.com - November 7 at 7:32 PM
Insider Buys Windtree Therapeutics StockInsider Buys Windtree Therapeutics Stock
benzinga.com - October 27 at 5:26 PM
Insider Buys Windtree Therapeutics SharesInsider Buys Windtree Therapeutics Shares
feeds.benzinga.com - October 9 at 11:52 AM
Windtree Therapeutics IncWindtree Therapeutics Inc
bloomberg.com - October 3 at 12:43 AM
Dosing underway in Windtree Therapeuticss mid-stage istaroxime study in heart diseaseDosing underway in Windtree Therapeutics's mid-stage istaroxime study in heart disease
seekingalpha.com - October 1 at 12:55 PM
Dosing underway in Windtree Therapeutics mid-stage istaroxime study in heart diseaseDosing underway in Windtree Therapeutics' mid-stage istaroxime study in heart disease
seekingalpha.com - October 1 at 12:55 PM
Bucks County biotech gets FDA approval to begin mid-stage testing of experimental Covid-19 therapyBucks County biotech gets FDA approval to begin mid-stage testing of experimental Covid-19 therapy
bizjournals.com - September 29 at 5:42 PM
Stock Alert: Windtree Therapeutics Jumps 22% As FDA Accepts IND Application For COVID-19 TreatmentStock Alert: Windtree Therapeutics Jumps 22% As FDA Accepts IND Application For COVID-19 Treatment
nasdaq.com - September 29 at 12:41 PM
Windtree to Present at H.C. Wainwright 22nd Annual Global Investment ConferenceWindtree to Present at H.C. Wainwright 22nd Annual Global Investment Conference
finance.yahoo.com - September 8 at 8:25 AM
WINT: Advancing Two Lead Fast Track-Designated Drug Candidates Toward Approval & CommercializationWINT: Advancing Two Lead Fast Track-Designated Drug Candidates Toward Approval & Commercialization
finance.yahoo.com - August 31 at 11:38 AM
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business UpdatesWindtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
finance.yahoo.com - August 13 at 8:03 PM
Windtree Adds to Team with Appointment of Three Industry VeteransWindtree Adds to Team with Appointment of Three Industry Veterans
finance.yahoo.com - July 21 at 11:04 AM
New finance chief for WindtreeNew finance chief for Windtree
seekingalpha.com - July 20 at 7:46 AM
Windtree Appoints John Hamill as Chief Financial OfficerWindtree Appoints John Hamill as Chief Financial Officer
finance.yahoo.com - July 20 at 7:46 AM
Did Windtree Therapeutics, Inc. (NASDAQ:WINT) Insiders Buy Up More Shares?Did Windtree Therapeutics, Inc. (NASDAQ:WINT) Insiders Buy Up More Shares?
finance.yahoo.com - June 30 at 2:00 PM
BRIEF-Windtree Announces Initial European Trial Sites Activated In Aerosurf Bridging StudyBRIEF-Windtree Announces Initial European Trial Sites Activated In Aerosurf Bridging Study
www.reuters.com - June 24 at 11:27 PM
Why Windtree Therapeutics Shares Are Trading Higher TodayWhy Windtree Therapeutics Shares Are Trading Higher Today
www.benzinga.com - June 24 at 6:27 PM
Windtree Announces Initial European Trial Sites Activated in AEROSURF® Bridging Study and a Collaboration for a Concomitant Independent Cerebral Physiology StudyWindtree Announces Initial European Trial Sites Activated in AEROSURF® Bridging Study and a Collaboration for a Concomitant Independent Cerebral Physiology Study
finance.yahoo.com - June 24 at 8:17 AM
Windtree Therapeutics Inc.Windtree Therapeutics Inc.
www.marketwatch.com - June 7 at 5:22 PM
Windtree to Host Company and Business Update Conference Call on June 4, 2020Windtree to Host Company and Business Update Conference Call on June 4, 2020
finance.yahoo.com - May 28 at 8:39 AM
Windtree Therapeutics Announces Closing of $23 Million Public Offering Including Full Exercise of Over-Allotment OptionWindtree Therapeutics Announces Closing of $23 Million Public Offering Including Full Exercise of Over-Allotment Option
finance.yahoo.com - May 22 at 8:08 PM
After returning PPP, Bucks County biotech working on Covid-19 therapy expects to raise $20MAfter returning PPP, Bucks County biotech working on Covid-19 therapy expects to raise $20M
www.bizjournals.com - May 21 at 6:06 PM
BRIEF-Windtree Therapeutics Reports Pricing Of $20.0 Mln Public OfferingBRIEF-Windtree Therapeutics Reports Pricing Of $20.0 Mln Public Offering
www.reuters.com - May 20 at 8:18 PM
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital MarketWindtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
finance.yahoo.com - May 20 at 10:16 AM
Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business UpdatesWindtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
finance.yahoo.com - May 14 at 10:12 AM
PPP loan recipient in Bucks County implements reverse stock split in pursuit of Nasdaq listingPPP loan recipient in Bucks County implements reverse stock split in pursuit of Nasdaq listing
www.bizjournals.com - April 29 at 5:20 PM
Windtree Announces First Patient Enrolled in AEROSURF® Bridging Study for the Treatment of Respiratory Distress SyndromeWindtree Announces First Patient Enrolled in AEROSURF® Bridging Study for the Treatment of Respiratory Distress Syndrome
finance.yahoo.com - April 29 at 5:20 PM
Windtree Therapeutics Announces Reverse Stock SplitWindtree Therapeutics Announces Reverse Stock Split
finance.yahoo.com - April 28 at 4:15 PM
Windtree Presents New Istaroxime Phase 2b Study Analysis at the American College of Cardiology (ACC) CongressWindtree Presents New Istaroxime Phase 2b Study Analysis at the American College of Cardiology (ACC) Congress
finance.yahoo.com - April 6 at 1:32 PM
Windtree Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Key Business UpdatesWindtree Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Key Business Updates
finance.yahoo.com - April 2 at 8:25 PM
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.